Sale disclosed
Ronald W. Penczek
CAO & Controller
Common Stock
- Reported value
- $148.77K
- Reported price
- $403.16 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Elevance Health, Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
CAO & Controller
Common Stock
Director
Common Stock
CAO & Controller
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| CAO & Controller | Common StockSale | 369$403.16 / share | $148.77K | Jun 12Filed Jun 15 · 3d later | SEC filing |
| Director | Common StockSale | 151$401.77 / share | $60.67K | Jun 11Filed Jun 12 · 1d later | SEC filing |
| CAO & Controller | Common StockSale | 1,531$403.13 / share | $617.19K | May 19Filed May 20 · 1d later | SEC filing |
Elevance Health, Inc. Common Stock · Stock
The filing reports a purchase for the member.
Elevance Health, Inc. Common Stock · Stock
The filing reports a purchase for a joint account.
Markwayne MullinReporting Senate member$752,554 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.